Publikationen, an denen er mitarbeitet RAMON SOTO OTERO (16)

2019

  1. Copper Increases Brain Oxidative Stress and Enhances the Ability of 6-Hydroxydopamine to Cause Dopaminergic Degeneration in a Rat Model of Parkinson’s Disease

    Molecular Neurobiology, Vol. 56, Núm. 4, pp. 2845-2854

2017

  1. Effects of Aluminium on Rat Brain Mitochondria Bioenergetics: an In vitro and In vivo Study

    Molecular Neurobiology, Vol. 54, Núm. 1, pp. 563-570

2016

  1. Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration

    Cell Death and Disease, Vol. 7, Núm. 10

2013

  1. A simple method for isolating rat brain mitochondria with high metabolic activity: Effects of EDTA and EGTA

    Journal of Neuroscience Methods, Vol. 213, Núm. 1, pp. 39-42

2012

  1. 2-Benzazepine nitrones protect dopaminergic neurons against 6-hydroxydopamine-induced oxidative toxicity

    Archiv der Pharmazie, Vol. 345, Núm. 8, pp. 598-609

2009

  1. Brain oxidative stress and selective behaviour of aluminium in specific areas of rat brain: Potential effects in a 6-OHDA-induced model of Parkinson's disease

    Journal of Neurochemistry, Vol. 109, Núm. 3, pp. 879-888

2007

  1. Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons

    Neurobiology of Aging, Vol. 28, Núm. 4, pp. 555-567

  2. Time-course of brain oxidative damage caused by intrastriatal administration of 6-hydroxydopamine in a rat model of Parkinson's disease

    Neurochemical Research, Vol. 32, Núm. 1, pp. 99-105

2006

  1. Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism

    Neuropharmacology, Vol. 51, Núm. 1, pp. 112-120

2005

  1. Angiotensin-converting enzyme inhibition reduces oxidative stress and protects dopaminergic neurons in a 6-hydroxydopamine rat model of Parkinsonism

    Journal of Neuroscience Research, Vol. 81, Núm. 6, pp. 865-873

2004

  1. Systemic Administration of N-Acetylcysteine Protects Dopaminergic Neurons Against 6-Hydroxydopamine-Induced Degeneration

    Journal of Neuroscience Research, Vol. 76, Núm. 4, pp. 551-562

2002

  1. Effects of (-)-nicotine and (-)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity: Relevance for Parkinson's disease

    Biochemical Pharmacology, Vol. 64, Núm. 1, pp. 125-135

  2. Effects of aluminum and zinc on the oxidative stress caused by 6-hydroxydopamine autoxidation: Relevance for the pathogenesis of Parkinson's disease

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1586, Núm. 2, pp. 155-168

2001

  1. Effect of iron and manganese on hydroxyl radical production by 6-hydroxydopamine: Mediation of antioxidants

    Free Radical Biology and Medicine, Vol. 31, Núm. 8, pp. 986-998

  2. N-acetylcysteine enhances production of dopaminergic neurons from mesencephalic-derived precursor cells

    NeuroReport, Vol. 12, Núm. 18, pp. 3935-3938

2000

  1. Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: Potential implication in relation to the pathogenesis of Parkinson's disease

    Journal of Neurochemistry, Vol. 74, Núm. 4, pp. 1605-1612